Participation Announcement: Rising Biotech Challenge 2025 Demo Day

Our CEO, Makoto Yamamoto, has been invited to present at the “Rising Biotech Challenge 2025 DEMO DAY,” hosted by Plug and Play Japan.

This event serves as the culmination of the TOKYO SUTEAM life science accelerator program, where selected startups and academic teams will showcase their scientific achievements and commercialization plans.

Tokyo Nucleic Acid Synthesis will present its next-generation cancer immunotherapy platform based on hairpin DNA technology triggered by tumor-specific microRNAs.

The DEMO DAY offers a valuable opportunity to engage with leading researchers, pharmaceutical companies, and investors driving the future of biotech innovation.